Pulmonary manifestation of a cutaneous pathogen: a fatal report of Nocardia brasiliensis pneumonia in elderly with no apparent immunocompromised status
DOI:
https://doi.org/10.18203/2320-6012.ijrms20251333Keywords:
Nocardia brasiliensis, Pulmonary nocardiosis, Immunocompetent hosts, Diagnostic challenges, Antimicrobial susceptibility, Chronic obstructive pulmonary diseaseAbstract
Nocardiosis, a rare but potentially life-threatening opportunistic infection, typically affects immunocompromised individuals. However, this report describes an unusual case of primary pulmonary nocardiosis caused by a cutaneous pathogen-Nocardia brasiliensis in a previously healthy, immunocompetent woman. The patient, with a history of chronic obstructive pulmonary disease (COPD), presented with non-specific symptoms including fever, chest pain, productive cough, and progressive dyspnoea, initially leading to a diagnosis of acute exacerbation of COPD with bacterial pneumonia. However, further diagnostic investigation revealed the presence of Nocardia brasiliensis in sputum samples, confirmed by Gram staining and modified Ziehl-Neelsen (ZN) staining. Despite appropriate initial clinical suspicion, the patient was not started on targeted therapy with cotrimoxazole in a timely manner. As a result, her condition rapidly worsened, progressing to multi-organ dysfunction syndrome (MODS), and she succumbed to the infection before effective treatment could be initiated. This case highlights two rare findings: the atypical presentation of pulmonary nocardiosis in an immunocompetent host and its rapid progression, emphasizing the critical importance of timely diagnosis and intervention. This case underscores the diagnostic challenges posed by Nocardia species, which can mimic other pulmonary infections, such as tuberculosis or fungal pneumonia. Given the increasing incidence of nocardiosis, especially in individuals with chronic lung diseases like COPD, heightened clinical awareness, early microbiological diagnosis, and prompt initiation of appropriate antimicrobial therapy is essential to improving patient outcomes and preventing fatality.
Metrics
References
Ranjan R, Bir R, Jayanthi Gunasekaran, Yadav VS, Gupta RM. A Fatal Case of Multidrug-Resistant Pleural Nocardiosis by Nocardia otitidiscaviarum in an Immunosuppressed Patient: A Case Report and Literature Review. Curēus. 2024;16(1):e52071. DOI: https://doi.org/10.7759/cureus.52071
Gonzalez L, Venkatesan R, Amador P, Sanivarapu R, Rangaswamy B. Lung Nocardiosis in an Immunocompetent Patient. Chest. 2023;164(4):A1174-5. DOI: https://doi.org/10.1016/j.chest.2023.07.844
Mehrian P, Esfandiari E, Karimi MA, Memari B. Computed Tomography Features of Pulmonary Nocardiosis in Immunocompromised and Immunocompetent Patients. Pol J Radiol. 2015;80:13-7. DOI: https://doi.org/10.12659/PJR.892042
Yan H, Li Z, Xia H, Li Q, Bai H. A case report on mixed pulmonary infection of Nocardia nova, Mycobacterium tuberculosis, and Aspergillus fumigatus based on metagenomic next-generation sequencing. Frontiers in Public Health. 2022;10:927338. DOI: https://doi.org/10.3389/fpubh.2022.927338
Clinical and Laboratory Standards Institute (CLSI). Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard-Second Edition. CLSI document M24-A2 (ISBN 1-56238-746-4). Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087 USA. 2011.
Kiska DL, Hicks K, Pettit DJ. Identification of Medically Relevant Nocardia Species with an Abbreviated Battery of Tests. J Clin Microbiol. 2002;40(4):1346-51. DOI: https://doi.org/10.1128/JCM.40.4.1346-1351.2002
Bailey and Scott’s Diagnostic Microbiology. Google Books. 2021. Available at: https://books.google.co.in/books?id=l8UZEAAAQBAJ. Accessed on 12 December 2024.
Brown-Elliott BA, Brown JM, Conville PS, Wallace RJ Jr. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev. 2006;19(2):259-82. DOI: https://doi.org/10.1128/CMR.19.2.259-282.2006
Wauters G, Avesani V, Charlier J, Janssens M, Vaneechoutte M, Delmée M. Distribution of nocardia species in clinical samples and their routine rapid identification in the laboratory. J Clin Microbiol. 2005;43(6):2624-8. DOI: https://doi.org/10.1128/JCM.43.6.2624-2628.2005
Saubolle MA, Sussland D. Nocardiosis: review of clinical and laboratory experience. J Clin Microbiol. 2003;41(10):4497-501. DOI: https://doi.org/10.1128/JCM.41.10.4497-4501.2003
Wang X, Yang H, Xie Y, Xian X. Severe disseminated Nocardia brasiliensis pneumonia with normal immune function: A case report. Medicine. 2024;103(1):e36402-2. DOI: https://doi.org/10.1097/MD.0000000000036402
Li S, Xu X, Wu M, Zhu J, Cen P, Ding J, et al. Lymphocutaneous nocardiosis caused by Nocardia brasiliensis in an immunocompetent patient: a case report. J Int Med Res. 2020;48(1):300060519897690. DOI: https://doi.org/10.1177/0300060519897690
Iwabayashi M, Takiguchi J, Tomioka H. A case of pulmonary nocardiosis with Nocardia brasiliensis spread from a post‐traumatic cutaneous infection in an immunocompetent patient. Respirol Case Rep. 2023;11(10):e01227. DOI: https://doi.org/10.1002/rcr2.1227
Rivière F, Billhot M, Soler C, Vaylet F, Margery J. Pulmonary nocardiosis in immunocompetent patients: can COPD be the only risk factor? Eur Respir Rev. 2011;20(121):210-2. DOI: https://doi.org/10.1183/09059180.00002211
González-Jiménez P, Méndez R, Latorre A. Pulmonary Nocardiosis. A case report. Revista Española de Quimioterapia. 2022;35(1):114-6. DOI: https://doi.org/10.37201/req/s01.24.2022
Pannu S, Pannu AK. Primary pulmonary nocardiosis by Nocardia brasiliensis: A case report and review of Indian literature. J Family Med Prim Care. 2019;8:3035-8. DOI: https://doi.org/10.4103/jfmpc.jfmpc_576_19
Dumic I, Brown A, Magee K, Elwasila S, Kaljevic M, Antic M, et al. Primary Lymphocutaneous Nocardia brasiliensis in an Immunocompetent Host: Case Report and Literature Review. Medicina (Mex). 2022;58(4):488. DOI: https://doi.org/10.3390/medicina58040488